These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36002783)

  • 1. Remdesivir-induced Bradycardia is not Associated with Worse Outcome in Patients with COVID-19: A Retrospective Analysis.
    Pantazopoulos I; Mavrovounis G; Dimeas G; Zikos N; Pitsikou M; Rousogianni E; Mermiri M; Michou A; Spanos M; Maniotis C; Chalkias A; Laou E; Zakynthinos G; Chatzis D; Gourgoulianis K
    Am J Cardiovasc Drugs; 2022 Nov; 22(6):705-710. PubMed ID: 36002783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Characteristics and Implications of Bradycardia in COVID-19 Patients Treated with Remdesivir: A Single-Center Retrospective Cohort Study.
    Schreiber A; Bauzon JS; Batra K; Mohammed S; Lee K; Houshmand N; Pham U; Cosme C; Inciong K; Al-Taweel O; Nasser K; Rana J; Sossou C; Go A; Hawwass D; Diep J; Ahsan CH
    Clin Drug Investig; 2022 Sep; 42(9):763-774. PubMed ID: 35978159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precipitating factors of bradycardia after remdesivir administration: ICU admission and cutoff value for declining heart rate.
    Chen YZ; Lin MS; Lin YP; Liu YZ; Yang CJ
    J Microbiol Immunol Infect; 2023 Oct; 56(5):970-976. PubMed ID: 37407291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remdesivir for the Treatment of Severe COVID-19: A Community Hospital's Experience.
    Lee S; Santarelli A; Caine K; Schritter S; Dietrich T; Ashurst J
    J Am Osteopath Assoc; 2020 Dec; 120(12):926-933. PubMed ID: 33136164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remdesivir treatment and clinical outcome in non-severe hospitalized COVID-19 patients: a propensity score matching multicenter Italian hospital experience.
    Attena E; Caturano A; Annunziata A; Maraolo AE; De Rosa A; Fusco FM; Halasz G; Dall'Ospedale V; Conte M; Parisi V; Galiero R; Sasso FC; Fiorentino G; Russo V
    Eur J Clin Pharmacol; 2023 Jul; 79(7):967-974. PubMed ID: 37212843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remdesivir-associated bradycardia.
    Ching PR; Lee C
    BMJ Case Rep; 2021 Sep; 14(9):. PubMed ID: 34479903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Remdesivir use with bradycardia: A systematic review and meta-analysis.
    Ishisaka Y; Aikawa T; Malik A; Kampaktsis PN; Briasoulis A; Kuno T
    J Med Virol; 2023 Aug; 95(8):e29018. PubMed ID: 37539782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential remdesivir-related transient bradycardia in patients with coronavirus disease 2019 (COVID-19).
    Pallotto C; Suardi LR; Gabbuti A; Esperti S; Mecocci L; Blanc P
    J Med Virol; 2021 May; 93(5):2631-2634. PubMed ID: 33620107
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety and heart rate changes in Covid-19 patients treated with Remdesivir.
    Brunetti ND; Poliseno M; Bottalico IF; Centola A; Montemurro L; Sica S; Santantonio T; Lo Caputo S
    Int J Infect Dis; 2021 Nov; 112():254-257. PubMed ID: 34551344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remdesivir-induced bradycardia in patients hospitalized with SARS-CoV2 infection: a possible vagally-mediated mechanism.
    Filtz A; Carandina A; Fasiello A; Barbetta L; Lombardi R; Cinque F; Rizzi G; Ceriani E; Furlan L; Bellocchi C; Fracanzani AL; Hu C; Cogliati C; Canetta C; Peyvandi F; Montano N; Tobaldini E
    Intern Emerg Med; 2023 Mar; 18(2):359-366. PubMed ID: 36539604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remdesivir-induced bradycardia in a 26-year-old patient with COVID-19: a case report.
    Guziejko K; Talalaj J; Chorazy M; Groth M; Moniuszko-Malinowska A
    Infection; 2022 Dec; 50(6):1605-1613. PubMed ID: 35701724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time from symptoms onset to remdesivir is associated with the risk of ICU admission: a multicentric analyses.
    Alonso-Navarro R; Ramírez M; Masiá M; Paredes R; Montejano R; Povar-Echeverria M; Carratalà J; Salavert M; Bernal E; Dueñas C; Flores J; Fanjul F; Gutiérrez I; Rico V; Mateu L; Cadiñanos J; Berenguer J; Soriano A
    BMC Infect Dis; 2023 May; 23(1):286. PubMed ID: 37142994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remdesivir associated sinus bradycardia in patients with COVID-19: A prospective longitudinal study.
    Hajimoradi M; Sharif Kashani B; Dastan F; Aghdasi S; Abedini A; Naghashzadeh F; Mohamadifar A; Keshmiri MS; Noorali S; Lookzadeh S; Alizadeh N; Siri MA; Tavasolpanahi M; Abdolmohammadi Y; Shafaghi M; Rouhani ZS; Shafaghi S
    Front Pharmacol; 2022; 13():1107198. PubMed ID: 36733376
    [No Abstract]   [Full Text] [Related]  

  • 14. Transient asymptomatic bradycardia and remdesivir in COVID-19 patients.
    Adamo G; Amata M; Cannizzaro N; Chessari C; Sapienza GM; Capizzi GM; Battaglia S; Benfante A; Scichilone N
    Minerva Med; 2023 Aug; 114(4):463-468. PubMed ID: 35332758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Bradycardia Following Remdesivir Administration Through the US Food and Drug Administration American College of Medical Toxicology COVID-19 Toxic Pharmacovigilance Project.
    Devgun JM; Zhang R; Brent J; Wax P; Burkhart K; Meyn A; Campleman S; Abston S; Aldy K;
    JAMA Netw Open; 2023 Feb; 6(2):e2255815. PubMed ID: 36787141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19.
    Ohl ME; Miller DR; Lund BC; Kobayashi T; Richardson Miell K; Beck BF; Alexander B; Crothers K; Vaughan Sarrazin MS
    JAMA Netw Open; 2021 Jul; 4(7):e2114741. PubMed ID: 34264329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remdesivir-Induced Extreme Sinus Bradycardia in COVID-19.
    Wasef N; Hamilton S; Fatima T; Osgood E
    Cureus; 2022 Jul; 14(7):e27307. PubMed ID: 35910702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and potential risk factors for remdesivir-associated bradycardia in hospitalized patients with COVID-19: A retrospective cohort study.
    Alsowaida YS; Shehadeh F; Kalligeros M; Mylonakis E
    Front Pharmacol; 2023; 14():1106044. PubMed ID: 36817161
    [No Abstract]   [Full Text] [Related]  

  • 19. Remdesivir treatment in hospitalized patients affected by COVID-19 pneumonia: A case-control study.
    Boglione L; Dodaro V; Meli G; Rostagno R; Poletti F; Moglia R; Bianchi B; Esposito M; Borrè S
    J Med Virol; 2022 Aug; 94(8):3653-3660. PubMed ID: 35411627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remdesivir treatment for patients with moderate to severe COVID-19.
    Hasanoğlu İ; Güner R; Çelik İ; Kanat F; Batırel A; Telli GD; Eren E; Yıldız DS; Bozkurt İ; Kart KY; Şenoğlu S; Kazak E; Karaali R; Çelikbaş A; Pullukçu H; Çağatay AA; Ünal S; Erdinç Ş; Tabak F; Gül A; Alp E
    Turk J Med Sci; 2022 Aug; 52(4):880-887. PubMed ID: 36326369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.